HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Lo, W.-K. Search for Related Content PubMed PubMed Citation Articles by Lo, W.-K.

PERITONEAL DIALYSIS UTILIZATION AND OUTCOME: WHAT ARE WE FACING?

Department of Medicine, Tung Wah Hospital, Hong Kong SAR, PR China

Correspondence to: W.K. Lo, Department of Medicine, Tung Wah Hospital, 12 Po Yan Street, Hong Kong SAR, PR China.
wkloc{at}hkucc.hku.hk

Penetration of peritoneal dialysis (PD) varies tremendously across the world. It ranges from about 80% in Hong Kong and Mexico to just a few percentage points in the United States, Japan, and Germany. While PD is growing in China, India, and some Eastern European and South American countries, it is declining in many European and North American countries. In terms of outcomes, the survival of PD patients is generally comparable to that of hemodialysis (HD) patients and better than that of HD patients during the first few years on dialysis. According to the U.S. Renal Data System, survival of patients on PD has been improving faster than that of patients on HD. In terms of cost, PD is usually cheaper than HD. Hence, declining PD utilization is unjustified. Work is required to identify and overcome negative factors such as physician bias, unfair medical reimbursement systems, and poor patient education.

KEY WORDS: KEY WORDS:; Hemodialysis; utilization rate; patient survival; cost.

Copyright © 2007 by Multimed Inc.